Noncontiguous stage II grade 3 follicular lymphoma

Clinical trials for Noncontiguous stage II grade 3 follicular lymphoma explained in plain language.

Never miss a new study

Get alerted when new Noncontiguous stage II grade 3 follicular lymphoma trials appear

Sign up with your email to follow new studies for Noncontiguous stage II grade 3 follicular lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1 Completed 1

New combo shows promise for tough lymphomas

Disease control Completed

This study tested adding lenalidomide to a standard chemotherapy regimen (EPOCH-R) in 55 people with aggressive B-cell lymphomas linked to the MYC gene. The goal was to find the best dose and see if the combination improves how long patients live without their cancer getting wors…

Matched conditions: NONCONTIGUOUS STAGE II GRADE 3 FOLLICULAR LYMPHOMA

Phase 1/2 • Sponsor: University of Chicago • Aim: Disease control

Last updated Jun 27, 2026 11:01 UTC

Noncontiguous stage II grade 3 follicular lymphoma

Get alerted when new Noncontiguous stage II grade 3 follicular lymphoma trials appear

New combo shows promise for tough lymphomas